KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Capital Expenditures (2016 - 2023)

Palvella Therapeutics has reported Capital Expenditures over the past 9 years, most recently at -$11000.0 for Q4 2022.

  • Quarterly Capital Expenditures fell 101.16% to -$11000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2022, up 9.69% year-over-year, with the annual reading at $171000.0 for FY2023, 83.57% down from the prior year.
  • Capital Expenditures was -$11000.0 for Q4 2022 at Palvella Therapeutics, down from $34000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $1.9 million in Q1 2020 and troughed at -$840000.0 in Q3 2020.
  • The 5-year median for Capital Expenditures is $391500.0 (2018), against an average of $443800.0.
  • The largest YoY upside for Capital Expenditures was 1492.56% in 2020 against a maximum downside of 462.07% in 2020.
  • A 5-year view of Capital Expenditures shows it stood at $565000.0 in 2018, then soared by 108.14% to $1.2 million in 2019, then crashed by 50.85% to $578000.0 in 2020, then surged by 64.19% to $949000.0 in 2021, then tumbled by 101.16% to -$11000.0 in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Capital Expenditures are -$11000.0 (Q4 2022), $34000.0 (Q3 2022), and $629000.0 (Q2 2022).